Skip to content

Effect of Ayurvedic drug in indigestion

A Pharmaceutical Standardization of Amapachaka Vati and to evaluate its clinical efficacy on Amajirna

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/054661
Enrollment
30
Registered
2023-07-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K929- Disease of digestive system, unspecified

Interventions

None listed

Sponsors

Government Ayurved Hospital Vadodara
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with classical signs & symptoms of Amajirna

Exclusion criteria

Exclusion criteria: Patients below 18 years and above 70 years Pregnant women and lactating mother. Uncontrolled Diabetes Mellitus (RBS = 200 mg/dl) and Hypertension (=140/90mmHg) Any other known serious systemic illness like AIDS, Malignancy.

Design outcomes

Primary

MeasureTime frame
Relief in Sophaakshigandayo (Swelling of periorbital region and cheeks) Sadhyobhukta Evodgara (Eructation of previous food) Praseka (Salivation) Utklesha (Nausea) Gaurava (Heaviness in the body) classical sign and symptoms of Amajirna Timepoint: 14 days

Secondary

MeasureTime frame
improvement of Agni Bala in PatientTimepoint: 14 days

Countries

India

Contacts

Public ContactDr Jigisha Patel

Government Ayurved College Vadodara

vyas_krt@yahoo.co.in9426393726

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026